NCT06043102View on ClinicalTrials.gov

Study Evaluating the Efficacy and Safety of TheraClearX on Mitigating Mild to Moderate Acne

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 16, 2023

Primary Completion Date

September 18, 2023

Study Completion Date

September 18, 2023

Conditions
Acne
Interventions
DEVICE

TheraClearX

TheraClear®X combines vacuum pressure with a broadband light source (500 nm to 1,200 nm) to treat facial acne.

Trial Locations (1)

90266

Ablon Skin Institute & Research Center, Manhattan Beach

Sponsors

Collaborators (1)

Strata Skin Sciences
All Listed Sponsors
collaborator

Strata Skin Sciences

UNKNOWN

lead

Ablon Skin Institute Research Center

OTHER